Ulusaloğlu, Armağan CanAtıcı, TeomanErmutlu, CenkAkesen, Selcan2024-06-062024-06-062021-01-010300-0605https://doi.org/10.1177/0300060520984931https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7829528/https://hdl.handle.net/11452/41796ObjectiveThis study was performed to investigate the baseline serum titanium levels in patients with short-segment titanium alloy posterior instrumentation and to assess patient-, implant-, and surgery-related factors that might affect the serum titanium level.MethodTwo groups of patients were included in the study. The study group comprised 39 patients who had undergone short-segment posterior instrumentation from January 2013 to June 2016. The control group comprised 11 randomly selected patients who presented to the outpatient clinic with no history of orthopedic surgery. The serum titanium levels and inter-group differences were analyzed.ResultsThe mean serum titanium level was significantly higher in the study group than in the control group. No significant difference was observed between patients with different etiologies, implants used for fusion, numbers of instrumented segments, or postoperative durations.ConclusionThe serum titanium levels of patients with posterior lumbar spinal instrumentation are significantly higher than those of the normal population even after achievement of solid fusion. These levels are not affected by the use of transverse connectors, the use of cages, the operated segments, or the duration of implants.eninfo:eu-repo/semantics/openAccessSpinal fusionTitaniumCorrosionPosterior lumbar instrumentationImplant durationCagesScience & technologyLife sciences & biomedicineMedicine, research & experimentalPharmacology & pharmacyResearch & experimental medicineArticle00061285620000149110.1177/03000605209849311473-2300